首页 › 基金 › BAKER BROS. ADVISORS LP › ARWR
BAKER BROS. ADVISORS LP 对 ARWR 的持仓历史
ARROWHEAD PHARMACEUTICALS IN · 医疗保健
BAKER BROS. ADVISORS LP 在 Q3 2026 的 13F 申报中披露持有 ARWR(ARROWHEAD PHARMACEUTICALS IN)1,709,053 股,市值约 US$111.9M,约占其申报组合的 0.54%,在其申报持仓中市值排名第 20 位。 BAKER BROS. ADVISORS LP 最近 6 个申报季度中有 6 个季度披露了 ARWR 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
BAKER BROS. ADVISORS LP 对 ARWR 的持仓演变
BAKER BROS. ADVISORS LP 于 Q2 2025 首次披露 ARWR 持仓:939,174 股(约 US$14.8M)。 该持仓在 Q2 2026 达到峰值 1,992,783 股,市值约 US$162.4M。 在 6 次申报中,BAKER BROS. ADVISORS LP 2 次增持、2 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 1,709,053 股、市值约 US$111.9M,环比减持 -283,730 股。。 持仓曾出现大幅变动:Q3 2025 增持约 78% (随后一个季度股价上涨 92%)、Q4 2025 增持约 30% (随后一个季度股价下跌 6%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 939.17K | $14.84M | 新进 |
| Q3 2025 | 1.67M | $57.62M | 增持 |
| Q4 2025 | 2.18M | $144.44M | 增持 |
| Q1 2026 | 1.99M | $124.95M | 减持 |
| Q2 2026 | 1.99M | $162.43M | 持有 |
| Q3 2026 | 1.71M | $111.86M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ARWR 与 13F 数据
ARWR(ARROWHEAD PHARMACEUTICALS IN)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 ARWR,申报仓位最大的包括:Avoro Capital Advisors LLC (US$720.0M), Vestal Point Capital, LP (US$315.1M), FRED ALGER MANAGEMENT, LLC (US$213.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ARWR 的基金
- Avoro Capital Advisors LLC 11.00M 股 · $719.95M · Q3 2026
- Vestal Point Capital, LP 4.82M 股 · $315.14M · Q3 2026
- FRED ALGER MANAGEMENT, LLC 3.26M 股 · $213.09M · Q3 2026
- Siren, L.L.C. 2.29M 股 · $149.91M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 843.06K 股 · $55.18M · Q3 2026
- Western Financial Corp/CA 820.24K 股 · $53.68M · Q3 2026
更多关于 BAKER BROS. ADVISORS LP
常见问题
How long has BAKER BROS. ADVISORS LP held ARWR?
BAKER BROS. ADVISORS LP has disclosed ARWR holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is BAKER BROS. ADVISORS LP's current position in ARWR?
As of Q3 2026, BAKER BROS. ADVISORS LP holds 1.71M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $111.86M, representing 0.54% of its reported portfolio and ranking #20.
Has BAKER BROS. ADVISORS LP been buying or selling ARWR?
In the latest 13F filing (Q3 2026), BAKER BROS. ADVISORS LP reduced its position in ARWR. The position peaked in Q2 2026 at 1.99M shares.
Which other funds hold ARWR?
Other major institutional holders of ARWR include Avoro Capital Advisors LLC, Vestal Point Capital, LP, FRED ALGER MANAGEMENT, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.